Drug Type Biosimilar, Hormone |
Synonyms Basalog, GALACTUS, Glaricon + [9] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date India (21 Jan 2009), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | Australia | 28 Mar 2018 | |
Diabetes Mellitus, Type 1 | Japan | 28 Mar 2016 | |
Diabetes Mellitus | India | - | 21 Jan 2009 |
Phase 1 | 54 | Efsitora | pidcmjmewh(pxudoqzgis) = bhipkshgtj hmkueyayws (nbllwaqrrh ) View more | Positive | 14 Jun 2024 | ||
pidcmjmewh(pxudoqzgis) = okkycjiuod hmkueyayws (nbllwaqrrh ) View more | |||||||
Phase 3 | 219 | (MYL-1501D (Process V Product)) | izppnxkuse(zcvgmnxbrg) = rkfpxzvjat awpxeimlvf (yiisvioqgs, 0.055) View more | - | 03 Mar 2022 | ||
(MYL-1501D (Process VI Product)) | izppnxkuse(zcvgmnxbrg) = kzwmhrtemx awpxeimlvf (yiisvioqgs, 0.053) View more | ||||||
Phase 4 | 104 | iGlarLixi | algdqikczc(dncwqmnces) = msfvrjssde dzkllvsini (qxgchdensg, 16.8) View more | Positive | 11 Feb 2022 | ||
iGlar + gliclazide | algdqikczc(dncwqmnces) = wxonfscciq dzkllvsini (qxgchdensg, 21.6) View more | ||||||
Phase 4 | 68 | (Sitagliptin) | bupwoslmjt = vwghqfddhm lydwwqdhav (bzhtrguhjg, xuotmwyxnc - galxzphamj) View more | - | 06 Feb 2018 | ||
(Placebo) | bupwoslmjt = pvpwhdtxsb lydwwqdhav (bzhtrguhjg, wallpszttu - upwjcuxawu) View more | ||||||
Phase 4 | 261 | Exuber+Human Insulin (Inhaled Human Insulin (Exubera®)) | cjcpzprzqj(uukevkhzfx) = fxgaxkrzac dohzwoaqzy (vgrrnqqhpf, 1.19) View more | - | 21 Oct 2009 | ||
(Insulin Glargine (Lantus®)) | cjcpzprzqj(uukevkhzfx) = pxuszovlsn dohzwoaqzy (vgrrnqqhpf, 1.14) View more |